NF-κB inhibition compromises cardiac fibroblast viability under hypoxia

Experimental Cell Research

Volumn 317, Issue 7, 2011, Pages 899-909

  Sangeetha, M ^a   Pillai, Malini S ^a   Philip, Linda ^a   Lakatta, Edward G ^b   Shivakumar, K ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Bcl 2; Cardiac fibroblasts; Cell survival; CIAP 2; Hypoxia; NF B

Indexed keywords

3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; HETERODIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROPIDIUM IODIDE; PROTEIN P50;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BAY REGION BINDING SITE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FIBROBLAST; HUMAN; HYPOXIA; MALE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; WESTERN BLOTTING;

EID: 79952452723     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.12.024     Document Type: Article

References (42)

1. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodelling. Pharmacol. Ther. 2009, 123:255-278.
2. Souders C.A., Bowers S.L.K., Baudino T.A. Cardiac fibroblasts: the renaissance cell. Circ. Res. 2009, 105:1164-1176.
3. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodelling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 45:657-687.
4. Mayorga M., Bahi N., Ballester M., Comella J.X., Sanchis D. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J. Biol. Chem. 2004, 279:34882-34889.
5. Sun Y., Weber K.T. Infarct scar: a dynamic tissue. Cardiovasc. Res. 2000, 46:250-256.
6. Graham R.M., Frazier D.P., Thompson J.W., Haliko S., Wasserlauf B.J., Spiga M.G., Bishopric N.H., Webster A.K. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J. Exp. Biol. 2004, 207:3189-3200.
7. Crow M.T. Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes. Circ. Res. 2002, 91:183-185.
8. Kang P.M., Haunstetter A., Aoki H., Usheva A., Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 2000, 87:118-125.
9. 99mTc-labeled Annexin V. J. Nucl. Med. 2004, 45:1536-1541.
10. Walford G.A., Moussignac R.-L., Scribner A.W., Loscalzo J., Leopold J.A. Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathways. J. Biol. Chem. 2004, 279:4425-4432.
11. Loberg R.D., Vesely E., Brosius F.C. Enhanced glycogen synthase kinase-3$β activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J. Biol. Chem. 2002, 277:41667-41673.
12. Sarada S., Himadri P., Mishra C., Geetali P. Role of oxidative stress and NF-κ B in hypoxia induced pulmonary edema. Exp. Biol. Med. 2008, 233:1088-1098.
13. Fujioka S., Schmidt C., Sclabas G.M., Li Z., Pelicano H., Peng B., Yao A., Niu J., Zhang W., Evans D.B., Abbruzzese J.L., Huang P., Chiao P.J. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J. Biol. Chem. 2004, 279:27549-27559.
14. Lee R., Collins T. Nuclear factor-kappa B and cell survival: IAPs call for support. Circ. Res. 2001, 88:262-264.
15. Fan Y., Dutta J., Gupta N., Fan G., Gelinas C. Regulation of programmed cell death by NF-kappa B and its role in tumorigenesis and therapy. Adv. Exp. Med. Biol. 2008, 615:223-250.
16. Frantz S., Hu K., Bayer B., Gerondakis S., Strotmann J., Adamek A., Ertl G., Bauersachs J. Absence of NF-kappa B subunit p50 improves heart failure after myocardial infarction. FASEB J. 2006, 20:1918-1920.
17. Hidetsugu M., Ryuichi M., Toshie N., Motokuni A., Hironori N., Yoshiaki T., Kei Y., Jitsuo H., Kaneda Y., Toshio O. Hypoxia-induced endothelial apoptosis through nuclear factor-kB (NF-kB)-mediated bcl-2 suppression. Circ. Res. 2000, 86:974-981.
18. Mustapha S., Kirshner A., Moissac D.D., Kirshenbaum L.A. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H939-H945.
19. Kumaran C., Shivakumar K. Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1855-H1862.
20. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 1999, 19:2690-2698.
21. Maniatis T., Fritsch E.F., Sambrooks J. Molecular cloning: a laboratory manual 1982, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
22. Hernandez-Gutierrez S., Garcia-Pelaez I., Zentella-Dehesa A., Ramos-Kuri M., Hernandez-Franco P., Hernandez-Sanchez F., Rojas E. NF-kappa B signaling blockade by Bay 11-7085 during early cardiac morphogenesis induces alterations of the outflow tract in chicken heart. Apoptosis 2006, 11:1101-1109.
23. Nasu K., Nishida M., Ueda T., Yuge A., Takai N., Narahara H. Application of the nuclear factor-κB inhibitor BAY 11-7085 for the treatment of endometriosis: an in-vitro study. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E16-E23.
24. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725.
25. Dutta J., Fan Y., Gupta N., Fan G., Gélinas C. Current insights into the regulation of programmed cell death by NF-κB. Oncogene 2006, 25:6800-6816.
26. Mattson M.P., Meffert M.K. Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006, 13:852-860.
27. Beg A.A., Sha W.C., Bronson R.T., Ghosh S. D baltimore, embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995, 376:167-169.
28. Misra A., Haudek S.B., Knuefermann P., Vallejo J.G., Chen Z.J., Michael L.H., Sivasubramanian N., Olson E.N., Entman M.L., Mann D.L. Nuclear factor-kappa-B protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation 2003, 108:3075-3078.
29. Baetz D., Regula K.M., Karen E., Shaw J., Shilpa K., Natalia Y., Kirshenbaum L.A. Nuclear factor-κB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation 2005, 112:3777-3785.
30. Erl W., Hansson G.K., de Martin R., Draude G., Weber K.S., Weber C. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ. Res. 1999, 84:668-677.
31. Aoki M., Nata T., Morishita R., Matsushita H., Nakagami H., Yamamoto K., Yamazaki K., Nakabayashi M., Ogihara T., Kaneda Y. Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001, 38:48-55.
32. Schoemaker M.H., Ros J.E., Homan M., Trautwein C., Liston P., Poelstra K., Goor H.V., Jansen P.L.M., Moshage H. Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP-2) prevents apoptosis. J. Hepatol. 2002, 36:742-750.
33. Pablos J.L., Carreira P.E., Serrano L., Castillo P.D., Gomez-Reino J.J. Apoptosis and proliferation of fibroblasts during postnatal skin development and scleroderma in the tight-skin mouse. J. Histochem. Cytochem. 1997, 45:711-719.
34. Dong Z., Venkatachalam M.A., Wang J., Patel Y., Saikumar P., Semenza G.L., Force T., Nishiyama J. Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms. J. Biol. Chem. 2001, 276:18702-18709.
35. Dong Z., Wang J.Z., Yu F., Venkatachalam M.A. Apoptosis-resistance of hypoxic cells: multiple factors involved and a role for IAP-2. Am. J. Pathol. 2003, 163:663-671.
36. Crow M.T., Mani K., Nam Y.J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 2004, 95:957-970.
37. Yunbo W., Tingjun F., Miaomiao Y. Inhibitor of apoptosis proteins and apoptosis. Acta Biochim. Biophys. Sin. 2008, 40:278-288.
38. Hunter A.M., LaCasse E.C., Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007, 12:1543-1568.
39. Shivakumar K., Sollott S.J., Sangeetha M., Sapna S., Ziman B., Wang S., Lakatta E.G. Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2653-H2658.
40. Varfolomeev E., Blankenship J.W., Wayson S.M., Fedorova A.V., Kayagaki N., Garg P., Zobel K., Dynek J.N., Elliott L.O., Wallweber H.J., Flygare J.A., Fairbrother W.J., Deshayes K., Dixit V.M., Vucic D. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFκ-dependent apoptosis. Cell 2007, 131:669-681.
41. Van Antwerp D.J., Martin S.J., Verma I.M., Green D.R. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol. 1998, 8:107-111.
42. Tongtong Z., Rao J.N., Xin G., lan L., Zhang H.M., Strauch E.D., Bass B.l., Jian-Ying W. NF-κB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am. J. Physiol. Cell Physiol. 2004, 55:C1009-C1018.